UFSP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.91430000026938E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.53907999999037E-05 |
Normal-vs-Stage2 |
2.957900E-03 |
Normal-vs-Stage3 |
1.59370999999187E-05 |
Normal-vs-Stage4 |
4.80380000000835E-06 |
Stage1-vs-Stage2 |
8.582200E-01 |
Stage1-vs-Stage3 |
2.192000E-02 |
Stage1-vs-Stage4 |
8.580400E-02 |
Stage2-vs-Stage3 |
8.714000E-02 |
Stage2-vs-Stage4 |
7.564100E-02 |
Stage3-vs-Stage4 |
8.985400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.98749999996895E-06 |
Normal-vs-AfricanAmerican |
2.26899999999919E-06 |
Normal-vs-Asian |
5.412400E-04 |
Caucasian-vs-AfricanAmerican |
3.122200E-01 |
Caucasian-vs-Asian |
1.666420E-01 |
AfricanAmerican-vs-Asian |
2.285800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.42110000000972E-06 |
Normal-vs-Female |
4.610700E-04 |
Male-vs-Female |
4.168400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.0668000000047E-06 |
Normal-vs-Extreme_Weight |
1.203400E-04 |
Normal-vs-Obese |
5.90349999999296E-05 |
Normal-vs-Extreme_Obese |
5.082400E-03 |
Normal_Weight-vs-Extreme_Weight |
1.761770E-01 |
Normal_Weight-vs-Obese |
3.085800E-01 |
Normal_Weight-vs-Extreme_Obese |
4.135600E-01 |
Extreme_Weight-vs-Obese |
8.455800E-01 |
Extreme_Weight-vs-Extreme_Obese |
9.787800E-01 |
Obese-vs-Extreme_Obese |
9.060000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.7279999998141E-07 |
Normal-vs-Age(41-60Yrs) |
4.47000000000086E-05 |
Normal-vs-Age(61-80Yrs) |
8.42239999965244E-07 |
Normal-vs-Age(81-100Yrs) |
2.483200E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.936700E-03 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.676060E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.654000E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.793000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.094000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.901800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
6.40849999999915E-05 |
Normal-VS-Type2 PRCC |
4.45700000017979E-07 |
Normal-VS-KIRP CIMP |
1.9557022667982E-11 |
Normal-VS-Unclassified PRCC |
9.366500E-04 |
Type1 PRCC-VS-Type2 PRCC |
4.362300E-02 |
Type1 PRCC-VS-KIRP CIMP |
1.5530999997182E-07 |
Type1 PRCC-VS-Unclassified PRCC |
6.416600E-01 |
Type2 PRCC-VS-KIRP CIMP |
8.01200000011271E-07 |
Type2 PRCC-VS-Unclassified PRCC |
3.263400E-01 |
KIRP CIMP-VS-Unclassified PRCC |
1.57889999963245E-07 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.26310000003738E-06 |
Normal-vs-N1 |
1.48050000037259E-07 |
Normal-vs-N2 |
8.29100000000471E-05 |
N0-vs-N1 |
6.726100E-02 |
N0-vs-N2 |
1.165840E-01 |
N1-vs-N2 |
2.730600E-01 |
|
|